independent proliferation. Recently, we discovered that co-expression of SFFV gp55 and sf-Stk 6 is sufficient to transform NIH 3T3 and primary fibroblasts. In the current study, we demonstrate 7 that sf-Stk and its downstream effectors are critical to this transformation. Unlike SFFV-derived 8 erythroleukemia cells, which depend on PU.1 expression for maintenance of the transformed 9 phenotype, SFFV gp55-sf-Stk transformed fibroblasts are negative for PU
INTRODUCTION
inappropriate expression of the human homologue of sf-Stk, sf-RON has been reported in a 1 number of human cancers (2, 3) , our studies on SFFV-activated sf-Stk may have relevance for 2 understanding and treating these diseases. 3 Figure 1 shows that although the 8 SFFV-derived MEL line NP7 expresses a high level of PU.1, none could be detected in 9 transformed fibroblasts co-expressing SFFV gp55 and sf-Stk, although both lines express high 10 levels of SFFV gp55 and sf-Stk. Thus, transformation of sf-Stk-expressing rodent fibroblasts by 11 SFFV, unlike SFFV-transformation of erythroid cells, may be due primarily to its activation of 12 sf-Stk. 13
A C C E P T E D
Anchorage-independent transformation requires sf-Stk expression. If SFFV is transforming 14 sf-Stk-expressing fibroblasts by activating sf-Stk, the kinase should be phosphorylated only in 15 virus-infected cells. As shown in Figure 2A , sf-Stk becomes tyrosine phosphorylated in 16 NIH3T3/sf-Stk cells only after infection with SFFV, consistent with our earlier findings that the 17 kinase domain of sf-Stk is required for the transformation of fibroblasts (17) . NIH 3T3 cells that 18 co-express sf-Stk and SFFV (NIH 3T3/sf-Stk/SFFV) become transformed and are capable of 19 forming anchorage-independent colonies in soft agar and subcutaneous tumors in nude mice 20 (17) . In order to demonstrate that sf-Stk expression is necessary for maintaining the transformed 21 phenotype, an shRNA construct was used to knock down sf-Stk in these cells. Stable lines were 22 established from NIH 3T3/sf-Stk/SFFV cells that were transfected with an sf-Stk shRNA 23
on January 13, 2018 by guest http://jvi.asm.org/ Downloaded from construct or with a luciferase shRNA construct, which served as a vector control. Western 1 analysis of the shRNA stable lines indicated that the cells transfected with the sf-Stk shRNA 2 construct exhibited knockdown of sf-Stk protein to below the level of detection ( Figure 2B ) 3 while the luciferase shRNA line continued to express sf-Stk robustly. In contrast, expression of 4 SFFV gp55 and β-tubulin was comparable in both shRNA lines, indicating a specific knockdown 5 of sf-Stk rather than a general decrease in protein expression. The sf-Stk shRNA stable line 6 reverted to a normal phenotype as assessed by its appearance in monolayer culture ( Figure 2C ). 7
In order to test the relevance of sf-Stk expression to anchorage-independent growth, a hallmark 8 of transformation, the sf-Stk shRNA line and the luciferase shRNA line were plated in soft agar 9 in parallel with NIH 3T3/sf-Stk/SFFV and low passage parental NIH 3T3 cells, as positive and 10 negative controls, respectively. As previously shown (17) , NIH 3T3/sf-Stk/SFFV cells formed 11 numerous anchorage-independent colonies within two weeks, but low passage parental NIH 3T3 12 cells formed very few to none ( Figure 2D ). However, the sf-Stk shRNA line showed a dramatic 13 reduction in the number of anchorage-independent colonies, down to levels comparable to that of 14 low passage parental NIH 3T3 cells ( Figure 2D 
Inhibition of JNK, MEK, PI3K, or mTOR, but not inhibition of p38 MAPK, decreases 3
anchorage-independent growth of NIH 3T3 cells co-expressing SFFVgp55 and sf-Stk. 4 Having identified the p42/44 MAP kinase pathway, the PI3K-Akt pathway, and JNK1/2 as being 5 activated in the SFFVgp55-sf-Stk transformed fibroblasts, we sought to evaluate the importance 6 of these pathways to transformed growth using commercially available small molecule 7
inhibitors. All the inhibitors were first tested in a monolayer proliferation assay in order to 8 assess toxicity over a wide range of drug concentrations and to compare the effect of the drugs 9 on the parental NIH 3T3 cells versus the transformed cells. Drug concentrations that induced a 10 50 percent or less decrease in monolayer proliferation were then tested in the soft agar assay to 11 assess the impact on anchorage-independent growth. 12
As shown in Figure 6A shown). These data suggest that MEK contributes primarily to anchorage-independent 7 transformation. 8
To test the importance of the PI3K/Akt/mTOR pathway to monolayer proliferation and 9
anchorage-independent transformation, we used the PI3K inhibitor LY249002 and the mTOR 10 We found that sf-Stk is phosphorylated in NIH 3T3 cells only when they co-express 21 SFFV gp55. Because phosphorylation is required for activation of kinase activity, these results 22 are consistent with our earlier findings that the kinase domain of sf-Stk is required for 23 transformation, and that NIH 3T3/sf-Stk cells are not capable of transformed growth (17) . It is 1 also consistent with the fact that we observed high levels of constitutively phosphorylated 2 signaling molecules in NIH 3T3/sf-Stk/SFFV cells, but not in NIH 3T3/sf-Stk cells. NIH 3T3/sf-3 Stk/SFFV cells have higher levels of phosphorylated MEK1, ERK 1/2, Gab 1/2, Akt, PI3K, and 4 JNK 1/2. These effectors all contribute to growth/survival and are frequently upregulated in 5 cancers. These effectors also have the potential to be activated downstream of the EpoR (28). 6
Overlapping signals from SFFVgp55-activated sf-Stk and SFFV gp55-activated EpoR probably 7 act together to push SFFV-infected erythroid cells over a threshold into full-blown hyperplasia. 8
Signals from SFFVgp55-activated EpoR appear to be insufficient to reach this threshold since sf-9
Stk -/-mice do not develop splenomegaly in response to SFFV despite virus in the spleen ( The whole cell lysates used for the western blots assessing phosphoproteins were 18 prepared from both steady state and serum starved cells. In most cases the overall results were 19 the same for both conditions, but the differences in phosphorylation levels in the transformed and 20 parental lines were more prominent in the serum starved samples, due to the elimination of 21 background phosphorylation in response to serum factors. The one instance in which this was not 22 the case was that of phosphorylated p38 MAPK. While both the transformed and parental NIH 23
A C C E P T E D
on January 13, 2018 by guest http://jvi.asm.org/ Downloaded from 3T3 cells had low levels of phosphorylated p38 MAPK at steady state, only the parental NIH 1 3T3 cells heavily phosphorylated p38 MAPK in response to serum starvation. Indeed, this stress 2 response was essentially absent in the 3T3/sf-Stk/SFFV cells. Suppression of p38 MAPK has 3 been observed in fibroblasts and epithelial cells transformed by other molecular mechanisms (7, 4 11, 27). Thus, in addition to the activation of pro-growth/survival pathways, SFFVgp55-sf-Stk 5 transformed cells suppress the pro-apoptotic p38 MAPK stress response. 6
Targeting the downstream effectors of SFFV gp55-activated sf-Stk with small molecule 7 inhibitors proved to be very effective at decreasing the monolayer and anchorage independent 8 growth of NIH 3T3/sf-Stk/SFFV cells. Of all the inhibitors tested, the JNK inhibitor SP600125 9 and the putative kinase inhibitor luteolin were the most effective both in the monolayer 10 proliferation assay and the anchorage independence assay. In addition, both showed a selectivity 11 for NIH 3T3/sf-Stk/SFFV cells over the parental NIH 3T3 cells. The effectiveness of SP600125 12 in both assays indicates that JNK contributes to both proliferation and anchorage independence. 13 Since the cells in the latter assay are more effectively inhibited by lower concentrations of 14 SP600125, JNK may contribute more to transformation than to proliferation, but this could also 15 reflect the longer exposure of the cells to the drug in the soft agar assay (14 days versus 48 16 hours), which could amplify its effect. Because luteolin suppresses the phosphorylation of the 17 Stk-related kinase Met (9) and was effective in decreasing both the monolayer and anchorage-18 independent growth of NIH 3T3/sf-Stk/SFFV cells, it may be blocking transformation by 19 inhibiting the activity of sf-Stk, which is necessary for the transformation of fibroblasts by 20
SFFV. 21
In contrast, inhibition of MEK with two different compounds had little effect on 22 monolayer proliferation, but at the same concentrations had a profound effect on anchorage-23 independent growth. This indicates that the Ras/Raf/MAPK pathway primarily drives 1 anchorage-independence in NIH 3T3/sf-Stk/SFFV cells. The p38 MAPK inhibitor SB203580 2 had little effect on the number of anchorage-independent colonies observed, but several of these 3 colonies were unusually large, indicating that inhibition of basal p38 MAPK enhances growth of 4 NIH 3T3/sf-Stk/SFFV cells. In the monolayer proliferation assay this effect is more pronounced, 
